Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea · Delayed Price · Currency is KRW 6,040.00
-10.00 (-0.17%)
At close: Sep 11, 2026
Sinil Pharmaceutical Market Cap
Sinil Pharmaceutical has a market cap or net worth of 68.71 billion as of September 11, 2026. Its market cap has decreased by -4.28% in one year.
Market Cap
68.71B
Enterprise Value
28.02B
Revenue
86.82B
Ranking
n/a
PE Ratio
10.71
Stock Price
6,040.00
ChartMarket Cap Chart
Since November 20, 2000, Sinil Pharmaceutical's market cap has increased from 16.83B to 68.71B, an increase of 308.35%. That is a compound annual growth rate of 5.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 68.71B | -0.49% |
| Dec 30, 2025 | 69.05B | -5.60% |
| Dec 30, 2024 | 73.15B | -16.60% |
| Dec 28, 2023 | 87.71B | -9.43% |
| Dec 29, 2022 | 96.84B | -24.53% |
| Dec 30, 2021 | 128.31B | -48.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam-A Pharm. | 85.14B |
| KOREA PHARMA | 83.11B |
| Samik Pharmaceutical Company LTD. | 79.63B |
| Daehan Nupharm | 78.46B |
| BL Pharmtech | 75.91B |
| GL Pharm Tech | 72.59B |
| Polaris AI Pharma | 72.53B |
| Pharos iBio | 71.85B |